2 completed, 1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Gammanorm: new trials by email Literature Review of Gammanorm trials Research Report on Gammanorm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency Gammanorm, Other Subcutaneous Immunoglobulins - Secondary Immune Deficiency | Completed | Octapharma | 102 | 2017-09-25 | 2022-03-02 | |
| Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases Gammanorm - Autoimmune Diseases | Terminated | Octapharma | 60 | 2016-11-23 | 2021-03-10 | |
| Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps Gammanorm - Primary Immunodeficiency (PID) | Phase 4 | Completed | Octapharma | 31 | 2014-04-01 | 2018-09-05 |
Autoimmune Diseases (1) · Primary Immunodeficiency Diseases (1)
Octapharma (3)
France (3) · Martinique (1)